Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34228985.
- Also identified by DOI 10.1016/j.jpeds.2021.06.083 and PMC identifier 8253718.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Myocarditis
- Pericarditis
- SARS-CoV-2
- Vaccination
- Vaccines, Synthetic